Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ida Ayu Widya Anjani"'
The Risk of Antihypertensive Drug among Breast Cancer Patient: A Systematic Review and Meta-analysis
Autor:
Desak Made Wihandani, Ayu Dilia Febriani Wisnawa, Anak Agung Wiradewi Lestari, Putri Ayu Wulandari, I Gede Putu Supadmanaba, I Wayan Sudarsa, I Gede Krisna Arim Sadeva, Jonny Karunia Fajar, Putu Anda Tusta Adiputra, I Putu Yuda Prabawa, Ida Ayu Widya Anjani, Sinta Wiranata, Anak Agung Bagus Putra Indrakusuma
Publikováno v:
Open Access Macedonian Journal of Medical Sciences. 9:327-334
BACKGROUNDS: Breast cancer or breast carcinoma is the most common type of malignancy in women globally. According to the previous studies that indicate the usage of antihypertensive drugs may become a risk factor of cancer (beta-blockers [BBs], calci
Autor:
Putu Anda Tusta Adiputra, I Gede Putu Supadmanaba, I Putu Yuda Prabawa, I Wayan Sudarsa, Anak Agung Wiradewi Lestari, Sinta Wiranata, I Putu Gede Septiawan Saputra, Desak Made Wihandani, I Gusti Ayu Stiti Sadvika, Ida Ayu Widya Anjani
Publikováno v:
Open Access Macedonian Journal of Medical Sciences; Vol. 8 No. B (2020): B-Clinical Sciences; 1058-1063
BACKGROUND: Breast cancer tends to respond differently to treatments, which are usually determined by clinicopathological characteristics. Several studies evaluated the role of the peripheral blood test as diagnostic and prognostic markers in several
Autor:
Ida Ayu Widya Anjani, Anak Agung Bagus Putra Indrakusuma, I Gede Krisna Arim Sadeva, Putri Ayu Wulandari, Luh Made Mas Rusyati, Prima Sanjiwani Saraswati Sudarsa, I Gede Putu Supadmanaba, Desak Made Wihandani
Publikováno v:
Bali Dermatology and Venereology Journal. 3
Background: Melanoma is the most serious lethal skin cancer, affects the melanin producer cells (melanocytes). Surgery is the most common treatment, whereas for the advance stage the development of a treatment is recommended. BRAF (Dabrafenib and Vem
Autor:
Ni Made Ari Purwaningrum, Ida Ayu Widya Anjani, I Wayan Windi Artha, Desak Made Wihandani, Sinta Wiranata, I Gede Putu Supadmanaba
Publikováno v:
Jurnal Kesehatan Andalas. 9:245
Penatalaksanaan hepatitis C yang umum diberikan di Indonesia adalah terapi kombinasi Peg-IFNα dan RBV, namun terapi tersebut mempunyai efek samping seperti depresi, hipotiroidisme, memperlambat motorik, risiko kardiovaskular tinggi, dan lain sebagai